17067704

Coli S

2007

Myocardial infarction complicating the initial phase of an ovarian stimulation protocol.

17068620

Hu WH

2006

[Monocyte chemoattractant protein-1 and its correlation with lipoprotein in polycystic ovary syndrome].

17070182

Behera M

2006

Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.

17070190

Orio F

2006

Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005.

17070195

Jones MR

2006

Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome.

17070196

Bayar U

2006

Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial.

17071531

Canto P

2006

Mutation analysis of the WNT-4 gene in patients with polycystic ovary syndrome.

17071535

Homburg R

2006

Endometrial biopsy during induction of ovulation with clomiphene citrate in polycystic ovary syndrome.

17071536

Gulcelik NE

2006

Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome.

17071537

Chan CC

2006

The prevalence of polycystic ovaries in Chinese women with a history of gestational diabetes mellitus.

17072487

McClanahan KK

2006

Navigating adolescence with a chronic health condition: a perspective on the psychological effects of HAIR-AN syndrome on adolescent girls.

17074328

Rautio K

2007

Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study.

17074337

Palomba S

2006

Effects of metformin and clomiphene citrate on ovarian vascularity in patients with polycystic ovary syndrome.

17074350

Yildiz BO

2006

Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.

17074730

Gursoy A

2006

Mean platelet volume in patients with polycystic ovary disease.

17076187

Ska?ba P

2006

[Analysis of leptin pulses in serum in women with polycystic ovary syndrome].

17076681

Haller K

2006

Controlled ovarian hyperstimulation changes the prevalence of serum autoantibodies in in vitro fertilization patients.

17077267

ACOG Committee on Adolescent Health Care.

2006

ACOG Committee Opinion No. 349, November 2006: Menstruation in girls and adolescents: using the menstrual cycle as a vital sign.

17077269

ACOG Committee on Adolescent Health Care.

2006

ACOG Committee Opinion No. 351, November 2006: The overweight adolescent: prevention, treatment, and obstetric-gynecologic implications.

17077476

Bablidze NI

2006

[Infertility structure in patients operated without effect due to polycystic ovaries].

17078127

Hensler P

2006

Viewpoint: Gender differences in heart disease.

17080748

Otto-Buczkowska E

2006

[Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].

17081535

Neveu N

2007

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.

17081819

Stein K

2006

Polycystic ovarian syndrome: what it is and why registered dietitians need to know.

17081931

King J

2006

Polycystic ovary syndrome.

17083810

Chu YL

2006

[Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance].

17084020

Birken S

2007

Patterns of LHbetacf among women in health and disease.

17085853

Krysiak R

2006

Update on the management of polycystic ovary syndrome.

17087783

Puder JJ

2006

Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia.

17089579

Tugrul S

2006

Significance of Doppler ultrasonography in the diagnosis of polycystic ovary syndrome.

17089862

Chia DJ

2006

Childhood obesity and the metabolic syndrome.

17090371

Hou LH

2006

[Therapeutic effects of Jinqi Jiangtang tablet on women with polycystic ovary syndrome].

17090372

Jia LN

2006

[Clinical observation on treatment of 43 women with polycystic ovary syndrome based on syndrome differentiation].

17090865

Kalra A

2006

Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome.

17097651

Maliqueo M

2007

Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome.

17098479

L?fgren E

2007

Reproductive endocrine function in women with epilepsy: the role of epilepsy type and medication.

17099212

Nader S

2007

Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis.

17103180

Takahashi K

2007

Odd variation of 75 g oral glucose tolerance test results in a Japanese patient with polycystic ovary syndrome: a case report.

17105841

Banaszewska B

2007

Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.

17106059

Vollmert C

2007

Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians.

17108879

La Marca A

2006

[Ovulation induction in anovulatory women].

17113210

Armanini D

2007

Treatment of polycystic ovary syndrome with spironolactone plus licorice.

17114870

Imamura K

2006

Ossification of the posterior longitudinal ligament of the thoracic spine in association with polycystic ovary syndrome.

17118366

S?nchez LA

2007

Determining the time androgens and sex hormone-binding globulin take to return to baseline after discontinuation of oral contraceptives in women with polycystic ovary syndrome: a prospective study.

17123696

Badawy A

2007

Plasma homocysteine and polycystic ovary syndrome: the missed link.

17123942

Tosca L

2007

Effects of metformin on bovine granulosa cells steroidogenesis: possible involvement of adenosine 5' monophosphate-activated protein kinase (AMPK).

17125045

Orio F

2006

[Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women].

17132756

Amato MC

2006

Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.

17134841

Kurzrock R

2007

Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.

17138841

Kempn? P

2007

Pioglitazone inhibits androgen production in NCI-H295R cells by regulating gene expression of CYP17 and HSD3B2.

17141766

Antoine HJ

2007

Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.

17141768

McGovern PG

2007

Utility of screening for other causes of infertility in women with known polycystic ovary syndrome.

17142128

Glueck CJ

2006

Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome.

17145568

Glueck CJ

2006

Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.

17145645

Cheang KI

2006

Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?

17145652

S?opie? R

2006

Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.

17148555

Wood JR

2007

Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis.

17148732

Charmandari E

2006

Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome?

17148733

Diamanti-Kandarakis E

2006

Stress in women: metabolic syndrome and polycystic ovary syndrome.

17148748

Vgontzas AN

2006

Obesity-related sleepiness and fatigue: the role of the stress system and cytokines.

17156261

Hamed SA

2007

The reproductive conditions and lipid profile in females with epilepsy.

17158782

Taniguchi F

2007

Estrogen receptor-alpha mediates an intraovarian negative feedback loop on thecal cell steroidogenesis via modulation of Cyp17a1 (cytochrome P450, steroid 17alpha-hydroxylase/17,20 lyase) expression.

17160211

Azevedo GD

2006

[Menstrual cycle irregularity as a marker of cardiovascular risk factors at postmenopausal years].

17161235

Diamanti-Kandarakis E

2007

Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.

17162710

Khattab S

2006

Metformin reduces abortion in pregnant women with polycystic ovary syndrome.

17162711

Kirilovas D

2006

Granulosa cell aromatase enzyme activity: effects of follicular fluid from patients with polycystic ovary syndrome, using aromatase conversion and [11C]vorozole-binding assays.

17163351

Komarowska H

2006

Ghrelin ovarian cell expression in patients with polycystic ovary syndrome: an immunohistochemical evaluation.

17166864

Baba T

2007

Association between polycystic ovary syndrome and female-to-male transsexuality.

17168480

Pekhlivanov B

2006

[Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome].

17168493

Pekhlivanov B

2006

[Quality of life in women with polycystic ovary syndrome].

17169171

Griesinger G

2006

GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis.

17169172

Engmann L

2006

GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS.

17172282

Nelson SM

2007

The preconceptual contraception paradigm: obesity and infertility.

17175469

Lee TF

2006

Comparison of day 2 tubal embryo transfer with day 3 embryo transfer into the uterus of intracytoplasmic sperm injection derived human embryos.

17175480

Oztekin O

2006

Spontaneous ovarian hyperstimulation syndrome in a normal singleton pregnancy.

17177140

Hahn S

2006

Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome.

17178014

Ireland K

2006

Polycystic ovary syndrome and the postmenopausal woman.

17179193

Rice S

2007

Stage-specific expression of androgen receptor, follicle-stimulating hormone receptor, and anti-M?llerian hormone type II receptor in single, isolated, human preantral follicles: relevance to polycystic ovaries.

17179197

Rosenfield RL

2007

Clinical review: Identifying children at risk for polycystic ovary syndrome.

17180658

Oztoprak I

2007

Complicated giant polycystic ovary mimicking tumor: MR imaging findings.

17182367

Mueller A

2006

Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.

17182709

Peri N

2007

Sonographic evaluation of the endometrium in patients with a history or an appearance of polycystic ovarian syndrome.

17185785

Teede HJ

2006

Polycystic ovarian syndrome: insights into the enigma that is PCOS today.

17185786

Broekmans FJ

2006

Diagnostic criteria for polycystic ovarian syndrome.

17185787

Diamanti-Kandarakis E

2006

Insulin resistance in PCOS.

17185788

Diamanti-Kandarakis E

2006

The role of genes and environment in the etiology of PCOS.

17185789

Gorry A

2006

Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment.

17185790

Norman RJ

2006

Lifestyle choices, diet, and insulin sensitizers in polycystic ovary syndrome.

17185791

Teede HJ

2006

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

17187005

Kos-Kud?a B

2006

Plasma ghrelin concentrations in patients with polycystic ovary syndrome before and after 6months therapy: correlation with androgen levels.

17189294

Ferk P

2007

The (TAAAA)n microsatellite polymorphism in the SHBG gene influences serum SHBG levels in women with polycystic ovary syndrome.

17197347

Lin YH

2006

In vitro maturation of human oocytes.

17197364

Liao CC

2006

Menstrual abnormalities in a woman with ACTH-dependent pituitary macroadenoma mimicking polycystic ovary syndrome.

17197418

Inzunza J

2007

Ovarian wedge resection restores fertility in estrogen receptor beta knockout (ERbeta-/-) mice.

17198446

Ansarin H

2007

Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.

17199924

Lin JF

2006

[Exploration of the classification of polycystic ovarian syndrome].

17201295

Barruet R

2006

[Type 2 diabetes mellitus in children in black Africa: description of first five cases in Togo].

17201585

Vrbikova J

2006

Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary.

17201808

Diamanti-Kandarakis E

2007

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.

17201818

Orio F Jr

2007

Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome.